Release date: 2010-05-03

Greystone Associates Analyzes Demand Factors and Market Dynamics Driving Growth in Ten Major Therapeutic Segments

(PRZOOM - Press & Newswire) —  Amherst, NH, United States, 2010-05-03 - For injectable drug delivery, evolving product options provide opportunities, as well as risks


The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has been driven by changes at the technology, regulatory, and therapeutic levels, and resulted in an ongoing set of challenges and opportunities for market participants that has modified the dynamics of injectable drug development, created new business models and re-arranged supply chain relationships.

The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to the safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. As patients live longer and are diagnosed with chronic and often debilitating ailments, the result will be a dramatic increase in self-administration of drug therapies in non-traditional settings for a number of conditions. This trend is creating an increased interest in drug device design and packaging that is patient-friendly as well as cost-effective.

More information on the growth prospects and shifting market opportunities for injectable drugs can be found in a comprehensive report, researched and prepared by Greystone Associates. Injectable Drug Delivery: Drugs, Devices, Targets, Therapeutics and Forecasts examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight on the implications of recent developments on this evolving landscape.

About Greystone

Greystone Associates ( is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.


Agency / Source:

# # #
  Related Link:
 Contact name: Mark Smith -
  Related Link:
 Contact: 603-595-4340 / mksmith[.]
PRZOOM disclaims any content contained in these release. Our complete disclaimer appears on our disclaimer page. Issuers of releases are solely responsible for the accuracy of their content. All trademarks are the property of their respective owners.
© - - Press Release & Newswire Distribution Network.

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Persistence Market Research (P) Ltd

  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today